HKBU-led research team develops novel anti-viral targeted drug for nasopharyngeal cancer treatment
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first...
New HKBU-led study unveils COVID-19 transmission patterns and safety-conscious reopening plans
With the COVID-19 pandemic resulting in lockdowns in different parts of the world, from the US to many European nations, there have been intense debates on when and how we can safely reopen the economy. New research led by HKBU computer...
Staff Publications and Presentations (January 2015)
30 Jan 2015
HKBU research project receives HK$1 million boost from Health and Medical Research Fund in support of inhibitors development for treatment of Hepatitis C
22 Jan 2015
Chemistry scholar receives patent on drug tracking technique
20 Jan 2015
Staff Publications and Presentations (December 2014)
31 Dec 2014
HKBU and TWGHs jointly develop food waste compost with biopesticide properties by adding Chinese medicine herbal residue as bulking agent
15 Dec 2014
Staff Publications and Presentations (November 2014)
28 Nov 2014